ReviewMolecular biology reports2025
Mitochondrial function in intestinal ischemia-reperfusion injury: mechanisms and therapeutic perspectives.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Molecular Mechanisms, Dynamic Lesions, and Therapeutic Targets in Intestinal Ischemia-Reperfusion Injury: A Systematic Review.International journal of molecular sciences · 2026Pooled it
- Sepsis-associated gastrointestinal dysfunction: neuroimmune mechanisms, gut-brain axis disruption, and therapeutic potential of vagus nerve-targeted neuromodulation.Frontiers in medicine · 2026Review
- Ferroptosis in necrotizing enterocolitis: iron overload-driven intestinal injury and mechanistic insights.Frontiers in pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Intestinal ischemia-reperfusion injury is a common pathophysiological event in acute abdominal conditions, characterized by tissue damage, a systemic inflammatory response, and multiple organ dysfunction. Recent studies have highlighted the central role of mitochondrial dysfunction in the initiation and progression of intestinal ischemia-reperfusion injury. Mitochondria play a crucial role in energy metabolism, redox balance, and cell death signaling, making them significant targets for research and therapeutic interventions. Moreover, oxidative stress-induced mitochondrial dysfunction-manifested by excessive reactive oxygen species production, loss of membrane potential, and calcium imbalance-further exacerbates cellular damage and promotes inflammatory responses. This review systematically examines the pathological mechanisms through which mitochondria contribute to intestinal ischemia-reperfusion injury and explores potential therapeutic strategies targeting mitochondrial function. Future research should focus on integrating signaling pathway analysis with multi-level treatment strategies, fostering the translation of basic research into clinical practice, and ultimately providing both theoretical and practical frameworks for improving patient outcomes.
Indexed as
Identifiers
40751761What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.